Alternating bowel pattern: What do people mean?

Alimentary Pharmacology and Therapeutics

Volumn 23, Issue 12, 2006, Pages 1749-1755

  Choung, R S ^a   Locke III, G R ^a   Zinsmeister, A R ^b   Melton III, L J ^b   Talley, N J ^a  

^a MAYO CLINIC   (United States)

^b Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOATING; CONSTIPATION; CONTROLLED STUDY; DEFECATION DISORDER; DEFECATION HABIT; DIARRHEA; DISEASE ASSOCIATION; FECES INCONTINENCE; FEMALE; GASTROINTESTINAL SYMPTOM; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCUS SECRETION; POPULATION RESEARCH; PRIORITY JOURNAL; SELF REPORT; STATISTICAL ANALYSIS; STRUCTURED QUESTIONNAIRE; SYMPTOM;

ADULT; AGED; AGED, 80 AND OVER; ATTITUDE TO HEALTH; CONSTIPATION; DIARRHEA; HEALTH SURVEYS; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; QUESTIONNAIRES;

EID: 33744913311     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.02953.x     Document Type: Article

References (24)

1. Camilleri M Chey WY Mayer EA, et al. A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome. Arch Intern Med 2001 161 : 1733 40.
2. Camilleri M Northcutt AR Kong S Dukes GE McSorley D Mangel AW. Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomized, placebo-controlled trial. Lancet 2000 355 : 1035 40.
3. Novick J Miner P Krause R, et al. A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation. Aliment Pharmacol Ther 2002 16 : 1877 88.
4. Muller-Lissner SA Fumagalli I Bardhan KD, et al. Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Aliment Pharmacol Ther 2001 15 : 1655 66.
5. Thompson WG Longstreth GF Drossman DA Heaton KW Irvine EJ Mueller-Lissner SAC. Functional bowel disorders and D. Functional abdominal pain. In : Drossman DA Corazziari E Talley NJ Thompson WG Whitehead WE, eds. Rome II: The Functional Gastrointestinal Disorders: Diagnosis, Pathophysiology and Treatment: a Multinational Consensus, 2nd edn. McLean, VA, USA : Degnon Associates, Inc., 2000 : 351 432.
6. Thompson WG Longstreth GF Drossman DA Heaton KW Irvine EJ Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999 45 : II43 7.
7. Tillisch K Labus JS Naliboff BD, et al. Characterization of the alternating bowel pattern subtype in patients with irritable bowel syndrome. Am J Gastroenterol 2005 100 : 896 904.
8. Guilera M Balboa A Mearin F. Bowel pattern subtypes and temporal patterns in irritable bowel syndrome: systematic review. Am J Gastroenterol 2005 100 : 1174 84.
9. Drossman DA Morris CB Hu Y, et al. A prospective assessment of bowel pattern in irritable bowel syndrome in women: defining an alternator. Gastroenterology 2005 128 : 580 9.
10. Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996 71 : 266 74.
11. Talley NJ Zinsmeister AR Melton LJ III. Irritable bowel syndrome in a community: symptom subgroups, risk factors and health care utilization. Am J Epidemiol 1995 142 : 76 83.
12. Talley NJ Zinsmeister AR Van Dyke C Melton LJ III. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1992 102 : 746.
13. Talley NJ Phillips SF Melton LJ Wiltgen C Zinsmeister AL. A patient questionnaire to identify bowel disease. Ann Intern Med 1989 111 : 671 4.
14. O'Keefe EA Talley NJ Tangalos EG Zinsmeister AR. A bowel symptom questionnaire for the elderly. J Gerontol 1992 47 : M116 121.
15. Melton LJ III. The threat to medical records research. N Engl J Med 1997 337 : 1466 70.
16. Talley NJ Zinsmeister AR Van Dyke C Melton LJ III. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991 101 : 927 34.
17. Talley NJ Boyce PM Owen BK Newman P Paterson KJ. Initial validation of a bowel symptom questionnaire and measurement of chronic gastrointestinal symptoms in Australians. Aust N Z J Med 1995 25 : 302 8.
18. Manning AP Thompson WG Heaton KW, et al. Towards positive diagnosis of the irritable bowel syndrome. Br Med J 1978 2 : 653 4.
19. Drossman DA Camilleri M Mayer EA, et al. AGA technical review on irritable bowel syndrome. Gastroenterology 2002 123 : 2108 31.
20. Mearin F Balboa A Badia X, et al. Irritable bowel syndrome subtypes according to bowel pattern: revisiting the alternating subtype. Eur J Gastroenterol Hepatol 2003 15 : 165 72.
21. Walter SA Skagerstrom E Bodemar G. Subgroups of irritable bowel syndrome: a new approach. Eur J Gastroenterol Hepatol 2004 16 : 991 4.
22. Mearin F Baro E Roset M Badia X Zarate N Perez I. Clinical patterns over time in irritable bowel syndrome: symptom instability and severity variability. Am J Gastroenterol 2004 99 : 113 21.
23. Agreus L Svardsudd K Nyren O Tibblin G. The epidemiology of abdominal symptoms: prevalence and demographic characteristics in a Swedish adult population. A report from the Abdominal Symptom Study. Scand J Gastroenterol 1994 29 : 102 9.
24. Talley NJ O'Keefe EA Zinsmeister AR Melton LJ III. Prevalence of gastrointestinal symptoms in the elderly: a population-based study. Gastroenterology 1992 102 : 895 901.